glucose, (beta-d)-isomer has been researched along with Dyspnea in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Manu, P | 1 |
| Chou, YM; Goh, ZNL; Lin, CC; Seak, CJ; Seak, CK; Seak, JC | 1 |
2 other study(ies) available for glucose, (beta-d)-isomer and Dyspnea
| Article | Year |
|---|---|
Drug Therapy for Unexplained Dyspnea in Post-COVID-19 Fatigue Syndrome: Empagliflozin and Sildenafil.
Topics: Benzhydryl Compounds; COVID-19; Dyspnea; Fatigue; Glucosides; Humans; Sildenafil Citrate | 2022 |
Euglycemic diabetic ketoacidosis caused by dapagliflozin: A case report.
Topics: Abdominal Pain; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Dyspnea; Fatigue; Female; Glucosides; Humans; Hypoglycemic Agents; Middle Aged; Nausea; Vomiting | 2018 |